HR 2821
Congress: 119th
Title: FDA Modernization Act 3.0
Updated: 2026-08-20T22:26:39Z
Latest Action: Received in the Senate. (2026-07-21)
Recorded Votes (1)
| Vote Number | Date | Action | Vote | Final chamber vote |
|---|---|---|---|---|
| 1 | 2026-07-20 | Voice VoteOn motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639) | passed | — |
Actions (14)
| Date | Chamber | Action | Type | Recorded Votes |
|---|---|---|---|---|
| 2026-07-21 | Senate | Received in the Senate. | IntroReferral | N/A |
| 2026-07-20 14:57:23 | House | Motion to reconsider laid on the table Agreed to without objection. | Floor | N/A |
| 2026-07-20 14:57:19 | House | On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639) | Floor | |
| 2026-07-20 14:47:33 | House | DEBATE - The House proceeded with forty minutes of debate on H.R. 2821. | Floor | N/A |
| 2026-07-20 14:47:31 | House | Considered under suspension of the rules. (consideration: CR H4639-4640) | Floor | N/A |
| 2026-07-20 14:47:16 | House | Mr. Guthrie moved to suspend the rules and pass the bill. | Floor | N/A |
| 2026-06-18 | House | Placed on the Union Calendar, Calendar No. 614. | Calendars | N/A |
| 2026-06-18 | House | Reported by the Committee on Energy and Commerce. H. Rept. 119-706. | Committee | N/A |
| 2026-05-21 | House | Ordered to be Reported by the Yeas and Nays: 44 - 0. | Committee | N/A |
| 2026-05-21 | House | Committee Consideration and Mark-up Session Held | Committee | N/A |
| 2026-05-13 | House | Forwarded by Subcommittee to Full Committee by Voice Vote. | Committee | N/A |
| 2026-05-13 | House | Subcommittee Consideration and Mark-up Session Held | Committee | N/A |
| 2026-04-10 | House | Referred to the Subcommittee on Health. | Committee | N/A |
| 2025-04-10 | House | Referred to the House Committee on Energy and Commerce. | IntroReferral | N/A |